Impact of margin status on survival following pancreatoduodenectomy for cancer: The Leeds Pathology Protocol (LEEPP)

HPB

Volumn 11, Issue 1, 2009, Pages 18-24

  Menon, Krishna V ^a   Gomez, Dhanwant ^a   Smith, Andrew M ^a   Anthoney, Alan ^a   Verbeke, Caroline S ^b  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Cancer; Margin; Pancreas; Resection; Survival

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT CANCER; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL PROTOCOL; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREATICODUODENECTOMY; PROGNOSIS; REPRODUCIBILITY; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 65749106750     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2008.00013.x     Document Type: Article

References (35)

1. Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G et al. (2005) Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer registry. Gut 54:385-387.
2. Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, Neoptolemos JP. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91:1410-1427.
3. Matsuno S, Egawa S, Unno M. (2007) R0 resection for ductal pancreatic cancer - Japanese experience. Am J Surg 194:S110-S114.
4. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess HH, Büchler MW. (2004) Curative resection is the single most important factor deterrnining outcome in patients with pancreatic adenocarcinoma. Br J Surg 91:586-594.
5. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P et al. (2001) Infiuence of resection margin on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 234:758-768.
6. Yeo C J, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA et al. (1997) Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes. Ann Surg 226:248-260.
7. Allema JH, Reinders ME, van Gulik TM, Koelemay MJ, Van Leeuwen DJ, de Wit LT et al. (1995) Prognostic factors for survival after pancreaticoduodenectomy or patients with carcinoma of the pancreatic head region. Cancer 75:2069-2076.
8. Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE et al. (2008) Influence of resection margins and treatment on survival in patients with pancreatic cancer. Meta-analysis of randomized controlled trials. Arch Surg 143:75-83.
9. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH et al. (2007) Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg 246:52-60.
10. Pingpank JF, Hoffman JP, Ross EA, Cooper HS, Meropol NJ, Freedman G et al. (2001) Effect of preoperative chemoradiotherapy on surgical margin status of resected adenocarcinoma of the head of the pancreas. J Gastrointest Surg 5:121-130.
11. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA et al. (2000) Resected adenocarcinoma of the pancreas - 616 patients: results, outcomes, and prognoetic indicators. J Gastrointest Surg 4:567-579.
12. Benassai G, Mastrorilli M, Quarto G, Cappiello A, Giani U, Mosella G. (2000) Survival after pancreaticoduodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital 52:263-270.
13. Sperti C, Pasquali C, Piccoli A, Pedrazzoli S. (1996) Survival after resection for ductal adenocarcinoma of the pancreas. Br J Surg 83:625-631.
14. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. (1995) Longterm survival affer resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 221:59-66.
15. Yeo C J, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN et al. (1995) Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 221:721-731.
16. Verbeke CS. (2008) Resection margins and R1 rates in pancreatic cancer - are we there yet? Histopathology 52:787-796.
17. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. (2006) Redefining the R1 resection in pancreatic cancer. Br J Surg 93:1232-1237.
18. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H et al. (2008) Most pancreatic cancer resections are R1 resections. Ann Surg Oncol 15:1651-1660.
19. Nagakawa T, Nagamori M, Futakami F, Tsukioka Y, Kayahara M, Ohta T et al. (1996) Results of extensive surgery for pancreatic carcinoma. Cancer 77:640-645.
20. Tsuchiya R, Noda T, Harada N, Miyamoto T, Tomioka T, Yamamoto K et al. (1986) Collective review of small carcinomas of the pancreas. Ann Surg 203:77-81.
21. Yeo C J, Sohn TA, Cameron JL, Hruban RH, L emoe KD, Pitt HA. (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821-831.
22. Van Geenen RCI, Van Gulik TM, Offerhaus GJA, De Wit LT, Busch ORC, Obertop H et al. (2001) Survival after pancreaticocluodenectomy for peri-ampullary adenocarcinoma: an update. Eur J Surg Oncol 27:549-557.
23. Berger AC, Watson JC, Ross EA, Hoffman JP. (2004) The metastatic/ examined lymph node ratio is an important prognostic factor afiar pancreaticoduodenectomy for pancreatic adenocarcinoma. Arn Surg 70:235-240.
24. House MG, Gönen M, Jarnagin WR, D'Angelica M, DeMatteo RP, Fong Y et al. (2007) Prognostic significance of pathologic nodal status in patients with resected pancreatic cancer. J Gastrointest Surg 11:1549-1555.
25. Willett CG, Lewandrowski K, Warschaw AL, Efird J, Compton CC. (1993) Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy. Ann Surg 217:144-148.
26. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. (1993) An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 72:2118-2233.
27. Westerdahl J, Andren-Sandberg A, Ihse I. (1993) Recurrence of exocrine pancreatic cancer: local or hepatic? Hepatogastroenterology 40:384-387.
28. Takai S, Satoi S, Toyokawa H, Yanagimoto H, Sugimoto N, Tsuji K et al. (2003) Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 26:243-249.
29. Kuhlmann KF, de Castro SM, Wesseling JG, ten Kate FJ, Offerhaus GJ, Busch OR et al. (2004) Surgical treatment of pancreatic adenocarcinoma: actual survival and prognostic factors in 343 patients. Eur J Cancer 40:549-558.
30. Tseng JF, Raut CP, Lee JE, Pisters PW, Vanthey JN, Abdalla EK et al. (2004) Pancreaticoduodenectomy with vascular resection: margin status and survival duration. J Gastrointest Surg 8:935-949.
31. Geer R J, Brennan MF. (1993) Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 165:68-73.
32. Millikan KW, Deziel DJ, Silverstein JC, Kanjo TM, Christein JD, Doolas A et al. (1999) Prognostic factors associated with respectable adenocarcinoma of the head of the pancreas. Am Surg 65:618-623.
33. Nagakawa T, Sanada H, Inagaki M, Sugama J, Ueno K, Konishi I et al. (2004) Longterm survivors after resection of carcinoma of the head of the pancreas: significance of histologically curative resection. J Hepatobiliary Pancreat Surg 11:402-408.
34. Bouvet M, Gamagami RA, Gilpin EA, Romeo O, Sasson A, Easter DW et al. (2001) Factors influencing survival after resection for periampullary neoplasms. Am J Surg 180:13-17.
35. Moon HJ, An JY, Heo JS, Choi SH, Joh JW, Kim YI. (2006) Predicting survival after surgical resection for aancreatic ductal adenocarcinoma. Pancreas 32:37-43.